Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

32.62
Delayed Data
As of May 24
 +0.50 / +1.56%
Today’s Change
27.62
Today|||52-Week Range
51.42
-23.71%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Wilkinson George Frederick
Chief Executive Officer
Sale4/29/201661,594$33.35$2.1M-2.19%
Wilkinson George Frederick
Chief Executive Officer
Sale10/29/201516,425$35.75$587.2K-8.76%
Markbreiter Charles Michael
Director
Sale8/26/201510,000$42.78$427.8K-24.89%
Markbreiter Charles Michael
Director
Sale8/31/201510,000$41.39$413.9K-20.36%
Markbreiter Charles Michael
Director
Sale8/31/201510,000$41.39$413.9K-20.36%
Fleming Nigel Ten
Director
Sale8/31/201510,000$41.02$410.2K-20.36%
Markbreiter Charles Michael
Director
Sale8/25/20159,399$41.67$391.7K-20.50%
Markbreiter Charles Michael
Director
Sale8/28/20158,000$42.48$339.8K-23.07%
Fleming Nigel Ten
Director
Sale8/31/20158,000$41.02$328.2K-20.36%
Schlossberg Mark A /impax/
General Counsel & Senior Vice President
Sale9/11/20157,457$43.30$322.9K-24.75%
Page of 6